SCHEMBL16232172

SCHEMBL16232172

CC(C)(C(=O)Cl)S(=O)(=O)c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 4/20 0.46
ALOX15 P16050 1/20 0.43
SMN1; SMN2 Q16637 3/20 0.42
HTT P42858 1/20 0.42
ALDH1A1 P00352 3/20 0.41
HSD17B10 Q99714 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
TSHR P16473 1/20 0.41
LMNA P02545 1/20 0.40
MAPT P10636 1/20 0.40
DUSP3 P51452 1/20 0.40
PTPN5 P54829 1/20 0.40
PTPN11 Q06124 1/20 0.40
HTR6 P50406 1/20 0.39
NPC1 O15118 1/20 0.39
RECQL P46063 1/20 0.39
RAB9A P51151 1/20 0.39
BCAT1 P54687 1/20 0.39
PSIP1 O75475 1/20 0.39
KMT2A Q03164 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1464395 0.83 HSD11B1 (0.48) HSD11B1ALOX15SMN1; SMN2ALDH1A1HSD17B10
SCHEMBL16232173 0.81 CNR2 (0.45) HSD11B1SMN1; SMN2ALDH1A1
SCHEMBL6550967 0.78 CES1 (0.45) HSD11B1ALOX15SMN1; SMN2ALDH1A1HSD17B10
SCHEMBL16842652 0.77 HSD11B1 (0.43) HSD11B1ALOX15SMN1; SMN2HTTTSHR
SCHEMBL16842663 0.77 HSD11B1 (0.51) HSD11B1ALOX15SMN1; SMN2ALDH1A1TSHR
SCHEMBL16842668 0.77 HDAC3 (0.52) HSD11B1
SCHEMBL5469341 0.74 HSD11B1 (0.41) HSD11B1ALOX15SMN1; SMN2ALDH1A1HSD17B10
SCHEMBL1464318 0.74 HSD11B1 (0.51) HSD11B1SMN1; SMN2HTTALDH1A1HSD17B10
SCHEMBL10652867 0.74 TSHR (0.48) HSD11B1ALOX15SMN1; SMN2ALDH1A1HSD17B10
SCHEMBL10604801 0.73 HSD11B1 (0.47) HSD11B1ALOX15SMN1; SMN2ALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150299184-A1 Amine Derivatives as Potassium Channel Blockers BIONOMICS LIMITED (AU) 2015-10-22 US disclosed
US-20150299184-A1 Amine Derivatives as Potassium Channel Blockers BIONOMICS LIMITED (AU) 2015-10-22 US disclosed
US-20140336198-A1 Amine Derivatives as Potassium Channel Blockers MERCK PATENT GMBH (DE) 2014-11-13 US disclosed
US-20140336198-A1 Amine Derivatives as Potassium Channel Blockers MERCK PATENT GMBH (DE) 2014-11-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140336198-A1 Amine Derivatives as Potassium Channel Blockers KCNA3, KCNH3, KCNK3 HSD11B1 4199/4885ALOX15 3201/4885SMN1; SMN2 2666/4885
US-20150299184-A1 Amine Derivatives as Potassium Channel Blockers KCNA3, KCNH3, KCNK3 HSD11B1 4199/4885ALOX15 3201/4885SMN1; SMN2 2666/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.